Franklin India Technology Fund-Growth vs WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Franklin India Technology Fund-Growth appears stronger due to its higher star rating of 5 compared to WhiteOak Capital Pharma and Healthcare Fund Direct Plan Growth's rating of 4, indicating a better overall assessment. However, investors should note that Franklin India Technology Fund has a higher expense ratio of 1.16% versus 1.06% for WhiteOak Capital, which could impact net returns. For those considering sector-specific investments, Franklin India offers more stability in terms of historical performance, while WhiteOak Capital shows impressive recent returns but lacks long-term data. Ultimately, investors should weigh the higher rating and historical performance of Franklin India against the lower expense ratio of WhiteOak Capital.

Franklin Templeton Mutual Fund

Franklin India Technology Fund-Growth

Franklin Templeton Mutual Fund

★★★★★

Equity · Sectoral

WhiteOak Capital Mutual Fund

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

WhiteOak Capital Mutual Fund

★★★★★

Equity · Sectoral

Metric Franklin India Technol... WhiteOak Capital Pharm...
NAV ₹544.36 ₹17.8
Star Rating ★★★★★ ★★★★
Expense Ratio 1.16% 1.06%
AUM ₹1,742 Cr ₹1,002 Cr
1M Return +5.45% +4.29%
3M Return -0.29% +2.5%
6M Return +13.03% +17.96%
1Y Return -5.8% +20.62%
3Y CAGR +10.29% —
5Y CAGR +7.22% —
Risk Level — —
Fund Manager Anand Radhakrishnan, Srikesh Nair, Varun Sharma Ashish Agrawal